Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
Authors
Keywords
-
Journal
npj Schizophrenia
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-21
DOI
10.1038/s41537-020-00135-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness
- (2019) Joseph F. Hayes et al. JAMA Psychiatry
- Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study
- (2019) Jose M. Rubio et al. PSYCHOLOGICAL MEDICINE
- COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
- (2019) Norbert Müller Frontiers in Psychiatry
- Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia
- (2018) Santiago G. Lago et al. ACS Chemical Neuroscience
- Calcium Channels, Synaptic Plasticity, and Neuropsychiatric Disease
- (2018) Evanthia Nanou et al. NEURON
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia—A Nationwide Study With 20-Year Follow-up
- (2017) Heidi Taipale et al. SCHIZOPHRENIA BULLETIN
- Microglial activation and progressive brain changes in schizophrenia
- (2016) L E Laskaris et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration
- (2016) Moshe Rogosnitzky et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Gout
- (2016) Nicola Dalbeth et al. LANCET
- Schizophrenia
- (2016) Michael J Owen et al. LANCET
- A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development
- (2016) A Cipriani et al. MOLECULAR PSYCHIATRY
- Purinergic receptors in psychiatric disorders
- (2016) Ute Krügel NEUROPHARMACOLOGY
- Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons
- (2016) Heidi Taipale et al. Clinical Epidemiology
- From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
- (2015) Antti Tanskanen et al. BMC Medical Informatics and Decision Making
- New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings
- (2015) Alex V. Kotlar et al. European Journal of Medical Genetics
- Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders
- (2015) Samuel Heyes et al. PROGRESS IN NEUROBIOLOGY
- Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy
- (2015) Famida G. Hoosain et al. Biomed Research International
- The Effects of Xanthine Oxidoreductase Inhibitors on Oxidative Stress Markers following Global Brain Ischemia Reperfusion Injury in C57BL/6 Mice
- (2015) Masahiro Yamaguchi et al. PLoS One
- Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons
- (2014) T Yoshimizu et al. MOLECULAR PSYCHIATRY
- Excess Early Mortality in Schizophrenia
- (2013) Thomas Munk Laursen et al. Annual Review of Clinical Psychology
- The P-Glycoprotein Transport System and Cardiovascular Drugs
- (2013) Jeffrey D. Wessler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adenosine hypothesis in schizophrenia and bipolar disorder: A systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators
- (2013) Tomoya Hirota et al. SCHIZOPHRENIA RESEARCH
- Medication for Attention Deficit–Hyperactivity Disorder and Criminality
- (2012) Paul Lichtenstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder
- (2012) Mark Weiser et al. SCHIZOPHRENIA RESEARCH
- Adenosine hypothesis of schizophrenia – Opportunities for pharmacotherapy
- (2011) Detlev Boison et al. NEUROPHARMACOLOGY
- Amelioration of Inflammation and Cytotoxicity by Dipyridamole in Brain Endothelial Cells
- (2010) Shuzhen Guo et al. CEREBROVASCULAR DISEASES
- A double-blind trial of adjunctive allopurinol for schizophrenia
- (2009) Faith B. Dickerson et al. SCHIZOPHRENIA RESEARCH
- The Role of Phosphodiesterases in Schizophrenia
- (2008) Judith A Siuciak CNS DRUGS
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
- (2008) György Haskó et al. NATURE REVIEWS DRUG DISCOVERY
- Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome?
- (2007) Philip J. Barter et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started